Profile data is unavailable for this security.
About the company
Labiana Health SA is a Spain-based holding company involved in the pharmaceuticals sector. The Company, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Company’s main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.
- Revenue in EUR (TTM)65.09m
- Net income in EUR-1.18m
- Incorporated2017
- Employees363.00
- LocationLabiana Health SAAV. EUROPA, 34 D 1a PLANTAPOZUELO DE ALARCON 28023SpainESP
- Websitehttps://www.labiana.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gelteq Ltd | 0.00 | -1.45m | 14.77m | -- | -- | 1.11 | -- | -- | -0.1599 | -0.1599 | 0.00 | 1.49 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 1.38 | -32.41 | 0.0605 | -- | -- | -- | -72.77 | -- | -- | -- |
| Cumberland Pharmaceuticals, Inc. | 35.84m | -9.84m | 15.15m | 91.00 | -- | 0.6093 | -- | 0.4227 | -0.7328 | -0.7328 | 2.67 | 1.87 | 0.4501 | 0.8643 | 3.17 | 415,225.80 | -12.35 | -7.03 | -17.75 | -9.52 | 82.58 | 79.95 | -27.45 | -17.64 | 1.26 | -38.85 | 0.382 | -- | -5.85 | 6.15 | -12.73 | -- | -36.17 | -- |
| Cosma SA | 915.23k | -10.89m | 15.31m | 31.00 | -- | 1.94 | -- | 16.72 | -0.4301 | -0.4301 | 0.0362 | 0.2343 | 0.0733 | 0.8409 | 3.05 | 136,278.60 | -87.24 | -- | -91.46 | -- | 58.45 | -- | -1,189.90 | -- | 0.5634 | -129.62 | 0.0119 | -- | -- | -- | -18,399.08 | -- | -- | -- |
| TherapeuticsMD Inc | 1.51m | -3.76m | 15.32m | 1.00 | -- | 0.5959 | -- | 10.12 | -0.3499 | -0.291 | 0.1399 | 2.35 | 0.0355 | -- | 0.4944 | 1,596,000.00 | -8.81 | -53.35 | -11.41 | -111.61 | 31.45 | 86.67 | -248.56 | -236.57 | -- | -- | 0.00 | -- | -98.14 | -39.53 | -816.85 | -- | -- | -- |
| Labiana Health SA | 65.09m | -1.18m | 15.45m | 363.00 | -- | 3.22 | 4.45 | 0.2374 | -0.1692 | -0.1692 | 9.27 | 0.6652 | 1.20 | 2.06 | 6.59 | 152,437.70 | -2.20 | -4.49 | -4.52 | -7.80 | 61.64 | 59.40 | -1.83 | -4.92 | 0.8015 | 0.9877 | 0.7459 | -- | 1.06 | 6.45 | 50.54 | -- | -9.47 | -- |
| Sotac Pharmaceuticals Ltd | 11.77m | 466.47k | 15.57m | 89.00 | 33.38 | 2.94 | 18.85 | 1.32 | 3.76 | 3.76 | 94.83 | 42.67 | 0.9762 | 4.92 | 3.77 | -- | 3.87 | -- | 7.26 | -- | 21.45 | -- | 3.96 | -- | 0.8132 | 2.77 | 0.3546 | -- | 79.07 | -- | -20.38 | -- | -- | -- |
| NicOx SA | -100.00bn | -100.00bn | 15.68m | 5.00 | -- | 0.7171 | -- | -- | -- | -- | -- | 0.3166 | -- | -- | -- | -- | -- | -22.59 | -- | -24.55 | -- | -- | -- | -337.85 | -- | -- | 0.5424 | -- | 26.59 | 11.38 | 33.26 | -- | -- | -- |
| Marinus Pharmaceuticals Inc | 29.85m | -133.27m | 15.77m | 165.00 | -- | -- | -- | 0.5283 | -2.47 | -2.47 | 0.5524 | -1.21 | 0.238 | 0.6542 | 7.75 | 190,703.00 | -106.26 | -49.64 | -140.93 | -57.76 | 90.17 | -- | -446.49 | -518.96 | 1.47 | -10.06 | -- | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
| Marinomed Biotech AG | 6.60m | -6.87m | 16.10m | 47.00 | -- | -- | -- | 2.44 | -4.46 | -4.46 | 4.28 | -7.69 | -- | -- | -- | 140,468.10 | -- | -33.46 | -- | -48.73 | 10.56 | 7.67 | -103.99 | -69.70 | 1.46 | -4.51 | 2.20 | -- | -18.56 | 14.50 | -6.21 | -- | -10.92 | -- |
| Cara Therapeutics Inc | 8.24m | -90.62m | 16.19m | 55.00 | -- | 24.13 | -- | 1.96 | -1.75 | -1.75 | 0.1589 | 0.0129 | 0.1042 | 0.6312 | 4.59 | 157,927.30 | -114.63 | -35.76 | -142.84 | -40.82 | 56.44 | -- | -1,099.76 | -162.10 | 4.71 | -- | 0.00 | -- | -49.92 | 9.26 | -38.65 | -- | 100.66 | -- |
Data as of Nov 15 2024. Currency figures normalised to Labiana Health SA's reporting currency: Euro EUR
0.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GVC Gaesco Gesti�n SGIIC SAas of 30 Jun 2024 | 8.00k | 0.11% |
Data from 30 Sep 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
